Cargando…
Allele-specific genome targeting in the development of precision medicine
The CRISPR-based genome editing holds immense potential to fix disease-causing mutations, however, must also handle substantial natural genetic variations between individuals. Previous studies have shown that mismatches between the single guide RNA (sgRNA) and genomic DNA may negatively impact sgRNA...
Autores principales: | Wu, Junjiao, Tang, Beisha, Tang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053192/ https://www.ncbi.nlm.nih.gov/pubmed/32194858 http://dx.doi.org/10.7150/thno.43298 |
Ejemplares similares
-
Targeted Therapies and Developing Precision Medicine in Gastric Cancer
por: Pihlak, Rille, et al.
Publicado: (2023) -
Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective
por: Chen, Zhao, et al.
Publicado: (2015) -
Immune targets for therapeutic development in depression: towards precision medicine
por: Drevets, Wayne C., et al.
Publicado: (2022) -
Targeting N-Terminal Huntingtin with a Dual-sgRNA Strategy by CRISPR/Cas9
por: Wu, Junjiao, et al.
Publicado: (2019) -
Systems Medicine for Precise Targeting of Glioblastoma
por: Zeng, Jie, et al.
Publicado: (2023)